Sierra Oncology Welcomes Two New Independent Directors to its Board

SAN MATEO, Calif.: —Georgia Erbez and Christy Oliger bring additional strategy, finance and commercial experience as Sierra prepares for commercialization of momelotinib— SAN MATEO, Calif., June 3, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of...

Click to view original post